Acneiform eruption during peficitinib treatment

Acneiform eruption during peficitinib treatment

Bibliographic Details
Main Authors:	Reiko Hara, Yu Sawada, Motonobu Nakamura
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Journal of Cutaneous Immunology and Allergy
Online Access:	https://doi.org/10.1002/cia2.12228

Similar Items

Afatinib-induced acneiform eruptions
by: Twinkle Singh Thakur, et al.
Published: (2022-01-01)

Deflazacort-induced Acneiform Eruptions
by: Mohammed Shakeel Mohammed Bashir, et al.
Published: (2017-01-01)

Acneiform eruption associated with the use of vortioxetine
by: Rukiye Ay, et al.
Published: (2019-04-01)

Vitamin B12 induced acneiform eruption
by: Imane Bahbouhi, et al.
Published: (2023-05-01)

Localized acneiform eruption induced by radiation therapy
by: Bader Sameer Zimmo
Published: (2018-01-01)

Acneiform eruptions and inflammatory striae as probable reactions to adalimumab
by: Shilpa Garg, et al.
Published: (2018-01-01)

Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib
by: Marco Caruana, MD, et al.
Published: (2020-10-01)

Haloperidol decanoate-induced acneiform eruption: A case report
by: Ihsan Aksoy, et al.
Published: (2018-09-01)

Unilateral acneiform eruption in a patient with history of contralateral Horner syndrome
by: Awadh Alamri, MBBS, PhD, et al.
Published: (2023-08-01)

Vellus hair cysts presenting as an atypical acneiform eruption Cisto de pelo velos apresentando-se como erupção acneiforme atípica
by: Hiram Larangeira de Almeida Jr, et al.
Published: (2011-08-01)

Erupção acneiforme aguda induzida por interferon beta-1b durante tratamento para esclerose múltipla Acute acneiform eruption induced by interferon beta-1b during treatment for multiple sclerosis
by: Dário Júnior de Freitas Rosa, et al.
Published: (2011-04-01)

Diagnostic Tools and Biomarkers for Severe Drug Eruptions
by: Manabu Yoshioka, et al.
Published: (2021-07-01)

Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab
by: Júlia Vide, et al.
Published: (2018-01-01)

Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib
by: Magnus Diller, et al.
Published: (2019-03-01)

A rare acneiform eruption presentation of Kikuchi-Fujimoto disease presenting with concurrent systemic lupus erythematosus
by: Morgan E. Decker, MD, MS, et al.
Published: (2023-10-01)

Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
by: Guan-Yi He, et al.
Published: (2012-06-01)

Exposure–response modeling of peficitinib efficacy in patients with rheumatoid arthritis
by: Junko Toyoshima, et al.
Published: (2021-05-01)

EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects
by: Júlia Kanaan Recuero, et al.
Published: (2023-08-01)

Extranodal natural killer/T-cell lymphoma, nasal type, presenting with acneiform eruptions: A previously undescribed variant
by: Chen-Pu Yeh, et al.
Published: (2020-01-01)

Management of acneiform rash associated with anti-EGFR monoclonal antibody treatment
by: E. A. Shatokhina, et al.
Published: (2020-12-01)

Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
by: Tsutomu Takeuchi, et al.
Published: (2020-03-01)

Maculopapular type drug eruption caused by silodosin
by: Akiha Inoue, et al.
Published: (2016-04-01)

Pharmacokinetics and Safety of Single and Multiple Doses of Peficitinib (ASP015K) in Healthy Chinese Subjects
by: Gao X, et al.
Published: (2022-05-01)

Segmental hypopigmented acneiform nevus with FGFR2 gene mutation
by: Yongyi Xie, et al.
Published: (2023-08-01)

Acneiform rash — skin toxic reaction to the use of EGFR inhibitors
by: E. A. Shatokhina, et al.
Published: (2019-01-01)

Scalp acneiform rash caused by erlotinib: a case report
by: Zhang Qian, Zhang Xin, Wang Qian, Zhou Xiyuan, Zhang Lixia
Published: (2023-07-01)

Panitumumab-induced acneiform rash in a patient with metastatic colon adenocarcinoma
by: Paulo Ricardo Saquete Martins-Filho, et al.
Published: (2013-01-01)

Melatonin Related Acneiform Lesions: A Case Report and Potential Mechanism
by: Baris Sancak, et al.
Published: (2021-06-01)

Peficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
by: Yuzo Ikari, et al.
Published: (2019-06-01)

Successful peficitinib addition on anti-MDA5 antibody-positive dermatomyositis refractory to triple therapy and glucocorticoid reduction
by: Yuki Oba, et al.
Published: (2022-12-01)

Maculopapular type drug eruption caused by pregabalin: A case and literature review
by: Akiha Inoue, et al.
Published: (2016-07-01)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
by: Fabienne Ballanger, et al.
Published: (2023-06-01)

Multiple fixed drug eruption caused by ropinirole in a patient with Parkinson's disease
by: Natsuko Sasaki-Saito, et al.
Published: (2016-04-01)

High S100A2 expression in keratinocytes in patients with drug eruption
by: Manabu Yoshioka, et al.
Published: (2021-03-01)

Hyper‐IgE syndrome in an 11 year old female presenting with acneiform rash
by: Berbie Byrne, et al.
Published: (2024-02-01)

IgA Vasculitis: Etiology, Treatment, Biomarkers and Epigenetic Changes
by: Hitomi Sugino, et al.
Published: (2021-07-01)

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study
by: Mark C. Genovese, et al.
Published: (2019-08-01)

Skin-limited Langerhans cell histiocytosis presenting as crusted papules in an acneiform distribution in an adolescent man
by: Rachel Choi, BA, et al.
Published: (2022-02-01)

A subcutaneous abscess following anti‐programmed cell death 1/programmed death‐ligand 1 antibody treatment for lung cancer
by: Hitomi Sugino, et al.
Published: (2022-06-01)

Daily Lifestyle and Cutaneous Malignancies
by: Yu Sawada, et al.
Published: (2021-05-01)